Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Dan Spillane who wrote (561)	2/5/1999 12:40:00 PM
From: ted	Read Replies (2) of 1298

has anyone tried talking with the company about their patent positions. I have emailed several times to Investor Relations regarding their claim of a broad aav patent covering "all therapies using an aav vector for delivery", but they have never responded. Targeted Genetics, on the other hand, has at least acknowledged the broad patent claims by other companies and has said they are "unconcerned, but looking further into it." They really musn't be too concerned, since they were able to work out a pharmaceutical deal for aav-CF treatment. It makes you wonder a bit about CEGE's claim.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next